Some links will work for NIAID staff only.
To provide funds for the completion or orderly termination of investigator-initiated clinical trials when a delay occurs due to circumstances the principal investigator (PI) could not foresee or control, the PI has adequately addressed reasons for the delay, and the clinical trial remains high priority for NIAID.
NIAID extends investigator-initiated clinical trials through a noncompetitive process that provides funds to investigators when their clinical trial is delayed because of unanticipated or uncontrollable circumstances. Find details in the January 30, 2007 Guide notice.
After a PI adequately explains the reasons for the delay and solves any problems, NIAID may extend a clinical trial if it remains a high priority and based on availability of funds.
A PI may be a candidate for an administrative noncompetitive extension when a clinical trial is delayed for any of the following reasons:
- Difficulties obtaining suitable study agent
- Difficulties meeting enrollment schedule
- Difficulties obtaining assurances and certifications
- Difficulties with access to suitable facilities
- External holdups at regulatory or funding agencies (not related to safety)
- Litigation involving any of the above
- Changes in public health policy or standards of care
NIAID does not issue administrative extensions for clinical trials delayed due to safety concerns, persistent systemic problems, suspended grant activities, or natural disasters. For the latter, go to NIH Extramural Response to Natural Disasters and Other Emergencies.
If a delay is due to vandalism or another isolated event unrelated to the trial, the PI should contact the program officer or grants management specialist.
- At least 18 months before a clinical trial grant ends, contact the Program Division Contact listed below to discuss the following:
- Status of your clinical trial
- Reason for the delay
- Assurance that all problems have been addressed
- Estimated time and funds needed to complete the study
- You can receive up to three years of support and may request funding up to the amount in the original grant. Escalation is not allowed. You may request a budget that exceeds these amounts if you provide adequate justification.
- NIAID program staff will determine if you are a candidate for an administrative extension and invite you to submit an application if your candidacy is approved.
- After you receive an invitation, submit an abbreviated PHS 398 paper application, progress reports, all data and safety monitoring board reports, and other related documentation to NIAID, including the invitation.
- Read the PHS 398 application instructions. Your application should contain only the pages and information listed in the January 30, 2007 Guide notice.
- Submit an application at least 90 days before an upcoming advisory Council meeting. NIAID conducts an internal programmatic evaluation of the application package.
- Administrative extension packages do not undergo peer review; do not send your application package to the NIH Center for Scientific Review (CSR) or submit electronically. Send a pdf with original signature to the Grants Management Contact listed below.
- NIAID program division staff will notify you in writing when the application is received, when NIAID will review the application, and the soonest possible award date.
- If PIs contact you to discuss administrative extensions, refer them to the Program Division Contact listed below.
- Your division follows the steps and approval actions described in the Investigator-Initiated Clinical Trial Administrative Extension Process Table.
Program Division Contacts
- Follow the steps and approval actions described in the Investigator-Initiated Clinical Trial Administrative Extension Process Table.
Grants Management Staff
- Follow the steps and approval actions described in the Investigator-Initiated Clinical Trial Administrative Extension Process Table
- The specialist assigned to the parent grant updates the Type 4 record in IMPAC
- Discuss type 4s, not review them en bloc
- Make a funding recommendation
Applicants with questions should contact the appropriate person listed below.
Contact for General Inquiries
If you have knowledge to share or want more information on this topic, email email@example.com with the title of this page or its URL and your question or comment. Thanks for helping us clarify and expand our knowledge base.